NZVC has invested in Bovonic, a Tauranga-based company innovating Bovine Mastitis detection with Quadsense™, poised to save farmers significant costs and revolutionize the dairy industry.

Target Information

Bovonic is a Tauranga-based company that is addressing the critical challenge of Bovine Mastitis, recognized as the most significant disease affecting the global dairy industry. Traditional methods for screening this condition are not only labor-intensive but also often yield inaccurate results, causing an estimated annual loss of $60,000 per dairy shed due to decreased production and health complications in animals. Bovonic has developed the Quadsense™, which is touted as the world's first affordable, easy-to-use, and precise detector for mastitis. This innovative solution utilizes in-cup sensors and machine learning technology to identify mastitis at its earliest stages, potentially saving farmers an average of $25,000 per dairy shed each year.

The company's leadership includes Liam Kampshof, a dairy farm-raised engineer with expertise in medical device development, alongside a team of experienced professionals in sales and engineering. They have also established a strong advisory board. After nearly three years of development in collaboration with a leading mastitis researcher, Bovonic has demonstrated the effectiveness and reliability of the Quadsense™ system, which has received pre-orders and letters of intent from significant industry players, indicating robust market interest.

Industry Overview

The global dairy industry faces severe challenges when it comes to diseases like Bovine Mastitis. The impact of such diseases not only affects the health of livestock but also translates into considerable financial losses for farmers. In countries such as New Zealand, the dairy sector con